osteosarcoma
Search results
Scope
Date
~
-
Bio & PharmaMedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
1
Latest News
- 1 Koramco targets $7 bn bets on Korea data centers
- 2 Lotte Chemical, HD Hyundai seek big deal via merger of naphtha cracking facilities
- 3 South Korea accelerates stablecoin framework in global race
- 4 Lee vows policy overhaul to spur dividend payouts
- 5 IFEZ to apply for designation of southern Gangwha as free economic zone
